As of November 2024, Boya Bio-pharmaceutical Group has a market cap of $2.20B. This makes Boya Bio-pharmaceutical Group the world's 4879th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.97B | -17.70% |
2023 | $2.40B | -7.88% |
2022 | $2.60B | -4.67% |
2021 | $2.73B | 14.34% |
2020 | $2.39B | 7.40% |
2019 | $2.22B | 15.71% |
2018 | $1.92B | -9.88% |
2017 | $2.13B | -20.28% |
2016 | $2.68B | 44.75% |
2015 | $1.85B | 94.97% |
2014 | $947.94M | 24.45% |
2013 | $761.68M | 37.79% |
2012 | $552.78M | - |